Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Receivables (2016 - 2025)

Historic Receivables for Perspective Therapeutics (CATX) over the last 15 years, with Q3 2025 value amounting to $179000.0.

  • Perspective Therapeutics' Receivables fell 1751.15% to $179000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $179000.0, marking a year-over-year decrease of 1751.15%. This contributed to the annual value of $603000.0 for FY2024, which is 4868.09% down from last year.
  • Latest data reveals that Perspective Therapeutics reported Receivables of $179000.0 as of Q3 2025, which was down 1751.15% from $225000.0 recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Receivables ranged from a high of $2.1 million in Q1 2022 and a low of $78000.0 during Q1 2025
  • Moreover, its 5-year median value for Receivables was $1.2 million (2022), whereas its average is $1.1 million.
  • The largest annual percentage gain for Perspective Therapeutics' Receivables in the last 5 years was 5845.07% (2025), contrasted with its biggest fall of 9219.22% (2025).
  • Perspective Therapeutics' Receivables (Quarter) stood at $1.6 million in 2021, then dropped by 17.12% to $1.4 million in 2022, then dropped by 13.92% to $1.2 million in 2023, then tumbled by 48.68% to $603000.0 in 2024, then crashed by 70.32% to $179000.0 in 2025.
  • Its Receivables stands at $179000.0 for Q3 2025, versus $225000.0 for Q2 2025 and $78000.0 for Q1 2025.